ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.19
0.99%
Dow Jones
39,721.36
1.09%
Brent Oil
85.365
0.37%
Bitcoin
57,370.17
-0.67%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
11/10/20221:49PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
11/10/202211:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
11/10/20226:25AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
11/08/20228:05AMGlobeNewswire Inc.Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBrNYSE:GSKGSK plc
11/07/20226:25PMDow Jones NewsADRs End Mostly Higher, GSK and Erste Group Bank Trade ActivelyNYSE:GSKGSK plc
11/07/20222:51AMDow Jones NewsGSK Says Dreamm-3 Phase 3 Study For Blenrep Didn't Meet Primary EndpointNYSE:GSKGSK plc
11/03/20226:56AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
11/03/20223:55AMDow Jones NewsGSK Stops Patient Enrolment for Gepotidacin Early Following IDMC ReviewNYSE:GSKGSK plc
11/02/202212:14PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
11/02/20227:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
11/02/20225:16AMDow Jones NewsGSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- UpdateNYSE:GSKGSK plc
11/02/20225:02AMTipRanksGSK Delivers Upbeat Q3 ResultsNYSE:GSKGSK plc
11/02/20224:05AMDow Jones NewsGSK Raises 2022 Guidance as 3Q Sales Beat ExpectationsNYSE:GSKGSK plc
11/01/202212:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/28/20229:18AMTipRanksHere’s Why GSK Stock (NYSE:GSK) is Trending Higher TodayNYSE:GSKGSK plc
10/28/20227:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/27/20228:47AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/21/202212:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/17/20222:54AMDow Jones NewsGSK Single-Vial Meningitis Treatment Approved by U.S. FDANYSE:GSKGSK plc
10/14/20229:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/13/20228:39AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/13/20228:31AMTipRanksGSK Plc (NYSE:GSK): RSV Vaccine Yields Positive ResultsNYSE:GSKGSK plc
10/13/20227:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/13/20222:45AMDow Jones NewsGSK Respiratory Syncytial Virus Vaccine Phase 3 Trial Meets Primary EndpointNYSE:GSKGSK plc
10/12/20227:38AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/11/20226:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/10/20222:48AMDow Jones NewsGSK Says US FDA Approves Boostrix for Immunization During PregnancyNYSE:GSKGSK plc
10/07/202212:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
10/03/20226:33AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/26/202212:45PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
FCEL
FuelCell Energy
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
AMEX
SPY
SPDR S&P 500
USOTC
VXIT
Virexit Technologies (PK)
USOTC
RNVA
Rennova Health (PK)
NASDAQ
AMRN
Amarin
USOTC
BIEL
Bioelectronics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved